Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition

doi:10.5306/wjco.v16.i3.94091

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1623)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

HTML

553

Figures (1-6)

161

Tables (1-2)

169

Sum=917

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

135

Download

358

Sum=493

Publishing Process of This Article

Item

Count

Browse

Download

128

Sum=164

Mar 24, 2025 (publication date) through Apr 15, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Mar 24, 2025; 16(3): 94091
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.94091

Full Size Figure Download Figure

Figure 5 Tumor growth and metastasis were examined by IVIS imaging system and quantified by bioluminescence intensity, and representative images were shown (n = 6). shNC: Short hairpin negative control; shRNA: Short hairpin RNA; OV: Overexpression lentivirus. ^aP < 0.01.

Citation: Li J, Wang ZY, Jin Y, Xu J, Ya YJ, Wan TQ, Li X, Wang X. Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition. World J Clin Oncol 2025; 16(3): 94091
URL: https://www.wjgnet.com/2218-4333/full/v16/i3/94091.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i3.94091